Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 282-617-7 | CAS number: 84281-74-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Acute oral Toxicity:
The acute oral toxicity dose (LD50) for 1,3-Benzenediamine, coupled with diazotized m-phenylenediamine, acetates (CAS no.: 84281-74-3) was considered based on data available for the structurally and functionally similar read across chemicals. The LD50 value is >2000 mg/kg bw. Thus, comparing this value with the criteria of CLP regulation, 1,3-Benzenediamine, coupled with diazotized m-phenylenediamine, acetates cannot be classified for acute oral toxicity.
Acute Inhalation Toxicity:
The acute inhalation toxicity study need not be conducted because exposure of humans via inhalation route is not likely taking into account due to the low vapour pressure of the substance 1,3-Benzenediamine, coupled with diazotized m-phenylenediamine, acetates (CAS no.: 84281-74-3), which is reported to be 1.29E-32 mmHg. Thus, exposure to inhalable dust, mist and vapour of the chemical 1,3-Benzenediamine, coupled with diazotized m-phenylenediamine, acetates is highly unlikely. Therefore this study is considered for waiver.
Acute dermal Toxicity:
The acute dermal toxicity dose (LD50) for 1,3-Benzenediamine, coupled with diazotized m-phenylenediamine, acetates (CAS no.: 84281-74-3) was considered based on data available for the structurally and functionally similar read across chemicals. The LD50 value is >2000 mg/kg bw. Thus, comparing this value with the criteria of CLP regulation, 1,3-Benzenediamine, coupled with diazotized m-phenylenediamine, acetates cannot be classified for acute dermal toxicity.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- data from handbook or collection of data
- Remarks:
- experimental data of read across substances
- Justification for type of information:
- Data for the target chemical is summarized based on the structurally and functionally similar read across chemicals.
- Reason / purpose for cross-reference:
- read-across source
- Reason / purpose for cross-reference:
- read-across source
- Qualifier:
- according to guideline
- Guideline:
- other: As mentioned below
- Principles of method if other than guideline:
- WoE report is based on two acute oral toxicity studies as- WoE-2 and WoE-3
Acute Oral toxicity test was carried out to study the effects of the test chemicals on rodents - GLP compliance:
- not specified
- Test type:
- other: not specified
- Limit test:
- no
- Specific details on test material used for the study:
- - IUPAC Name: 1,3-Benzenediamine, coupled with diazotized m-phenylenediamine, acetates
- Common Name: Basic Brown 1
- Molecular formula : C26H34N8O8
- Molecular weight : 586.597 g/mol
- Smiles notation : CC(=O)O{-}.N{+}c1ccc(N=Nc2cccc(N=Nc3ccc(N{+}.O{-}C(C)=O)cc3N{+}.O{-}C(C)=O)c2)c(N{+}.O{-}C(C)=O)c1
- Substance type : Organic
- Physical state : liquid - Species:
- rat
- Strain:
- other: 1. Tif. RAI rats 2. not specified
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- 1. TEST ANIMALS
- Source: No data
- Age at study initiation: 6 to 7 weeks old
- Weight at study initiation: Animals were weighed 160 to 180 g
- Fasting period before study: The rats were starved during one night before starting the treatment.
- Housing: The males and females were segregated and housed in Macrolon cages (Type 3) in groups of 5.
- Diet (e.g. ad libitum): food, ad libitum.
- Water (e.g. ad libitum): water, ad libitum.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 1° C
- Humidity (%): approximately 50 %
2. not specified - Route of administration:
- other: 1. oral: gavage 2. oral: unspecified
- Vehicle:
- other: 1. CMC (carboxymethyl cellulose) 2. unchanged (no vehicle)
- Details on oral exposure:
- 1. VEHICLE
- Concentration in vehicle: 50 and 60 %
DOSAGE PREPARATION (if unusual): Test material was suspended at 50 and 60 % with carboxymethylcellulose 2 % and administered by oral intubation.
2. not specified - Doses:
- 1. 6000 and 10000 mg/kg
2. 5000 mg/kg - No. of animals per sex per dose:
- 1. Total = 20 (sex/dose)
2. not specified - Control animals:
- not specified
- Details on study design:
- 1. - Duration of observation period following administration: 7 days
- Frequency of observations and weighing: Mortality and general symptoms was observed at 1 h, 24 h, 48 h, and 7 days.
- Necropsy of survivors performed: yes
- Other examinations performed: Animals were observed for clinical signs.
2. not specified - Statistics:
- 1. not specified
2. not specified - Preliminary study:
- 1. not specified
2. not specified - Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 10 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: No mortality was observed
- Sex:
- not specified
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: No mortality was observed
- Mortality:
- 1. No mortality was observed at 10000 mg/kg bw.
2. No mortality was observed at 5000 mg/kg bw. - Clinical signs:
- 1. Within 2 hours after treatment the rats of both dosage groups showed dyspnoea, exophthalmus, curved position and ruffled fur. The animals had recovered within 4 to 6 days.
2. not specified - Body weight:
- 1. not specified
2. not specified - Gross pathology:
- 1. No substance related gross organ changes were seen.
2. not specified - Other findings:
- 1. not specified
2. not specified - Interpretation of results:
- other: Not classified
- Conclusions:
- According to CLP regulation the test chemical 1,3-Benzenediamine, coupled with diazotized m-phenylenediamine, acetates (CAS no.: 84281-74-3) cannot be classified for acute oral toxicity, as the LD50 value is >2000 mg/kg bw.
- Executive summary:
Data available for the structurally and functionally similar read across chemicals has been reviewed to determine the acute oral toxicity of the test chemical 1,3-Benzenediamine, coupled with diazotized m-phenylenediamine, acetates (CAS no.: 84281-74-3). The studies are as mentioned below:
1. Acute oral toxicity test was conducted using test chemical in 20 Tif. RAI rats (10 males/10 females), bred under SPF conditions at the dose concentration of 6000 and 10000 mg/kg bw. The test substance was weighed into an Erlenmeyer flask on a Mettler balance. It was suspended at 50 and 60 % with carboxymethylcellulose 2 % and administered by oral intubation. Before treatment the suspension was homogeneously dispersed with an Ultra-Turrax and during treatment it was kept stable with a magnetic stirrer. Mortality and general symptoms was observed at 1 h, 24 h, 48 h, and 7 days. Animals were observed for clinical signs. No mortality was observed at any of the dose in treated rats. Within 2 hours after treatment the rats of both dosage groups showed dyspnoea, exophthalmus, curved position and ruffled fur. The animals had recovered within 4 to 6 days. They were killed and autopsied after an observation period of 7 days. No substance related gross organ changes were seen. Hence, LD50 was considered to be >10000 mg/kg bw, when Tif. RAI rats were treated with test chemical via oral gavage route.
2. Acute oral toxicity study of test chemical was conducted in rats at the concentration of 5000 mg/kg bw. No mortality was observed in treated rats at 5000 mg/kg bw. Therefore, LD50 was considered to be >5000 mg/kg bw, when rats were treated with test chemical via oral route.
Thus, based on the above summarised studies, 1,3-Benzenediamine, coupled with diazotized m-phenylenediamine, acetates (CAS no.: 84281-74-3) and it’s structurally and functionally similar read across substance, it can be concluded that LD50 value is >2000 mg/kg bw. Thus, comparing this value with the criteria of CLP regulation, 1,3-Benzenediamine, coupled with diazotized m-phenylenediamine, acetates cannot be classified for acute oral toxicity.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 10 000 mg/kg bw
- Quality of whole database:
- Data is Klimisch 2 and from study report.
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Data waiving:
- other justification
- Justification for data waiving:
- other:
Reference
Endpoint conclusion
- Quality of whole database:
- Waiver
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- data from handbook or collection of data
- Remarks:
- Experimental data of read across substances
- Justification for type of information:
- Data for the target chemical is summarized based on the structurally and functionally similar read across chemicals.
- Reason / purpose for cross-reference:
- read-across source
- Reason / purpose for cross-reference:
- read-across source
- Qualifier:
- according to guideline
- Guideline:
- other: As mentioned below
- Principles of method if other than guideline:
- WoE report is based on two acute dermal toxicity studies as- WoE 2.and WoE 3.
Acute dermal toxicity test was carried out to study the effects of the test chemicals on rodents - GLP compliance:
- not specified
- Test type:
- other: not specified
- Limit test:
- no
- Specific details on test material used for the study:
- - IUPAC Name: 1,3-Benzenediamine, coupled with diazotized m-phenylenediamine, acetates
- Common Name: Basic Brown 1
- Molecular formula : C26H34N8O8
- Molecular weight : 586.597 g/mol
- Smiles notation : CC(=O)O{-}.N{+}c1ccc(N=Nc2cccc(N=Nc3ccc(N{+}.O{-}C(C)=O)cc3N{+}.O{-}C(C)=O)c2)c(N{+}.O{-}C(C)=O)c1
- Substance type : Organic
- Physical state : liquid - Species:
- rat
- Strain:
- other: 1. not specified 2. Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- 1. not specified
2. TEST ANIMALS
- Source: National Institute of Biosciences, Pune.
- Females (if applicable) nulliparous and non-pregnant: [no]
- Age at study initiation: Young adult male and female rats aged between 6 – 9 weeks were used.
- Weight at study initiation: The weight ranges of approximately 210.2 to 245.4 grams at initiation of dosing were used.
Body weights at the start : Male Mean: 240.40 g (= 100 %); Minimum : 234.6 g (- 2.41 %); Maximum : 245.4 g (+ 2.08 %)
Female Mean: 215.98 g (= 100 %); Minimum : 210.2 g (- 2.68 %); Maximum : 220.6 g (+ 2.14 %)
- Housing: The rats were individually housed in polycarbonate cages with paddy husk as bedding.
- Diet (e.g. ad libitum): Rodent feed supplied by the Nutrivet Life Sciences, Pune, was provided ad libitum from individual feeders.
- Water (e.g. ad libitum): Water was provided ad libitum from individual bottles attached to the cages. All water was from a local source and passed through the reverse osmosis membrane before use. - Acclimation period: 5 days.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): Room temperature was maintained at 20.1 to 21.9 degree centigrade.
- Humidity (%): Room humidity was maintained at 55.5% to 59.2%.
- Air changes (per hr): The animal room was independently provided with at least ten to fifteen air changes per hour of 100% fresh air that had been passed through the HEPA filters.
- Photoperiod (hrs dark / hrs light): An artificial light and dark cycle of 12 hours each was provided to the room. - Type of coverage:
- other: 1. Dermal 2. semiocclusive
- Vehicle:
- other: 1. unchanged (no vehicle) 2. unchanged (no vehicle)
- Details on dermal exposure:
- 1. not specified
2. TEST SITE
- Area of exposure: Dorsal surface and sides from scapular to pelvic area.
- % coverage: Approximately 10% of the total body surface area.
- Type of wrap if used: Porous gauze dressing and non-irritating tape.
REMOVAL OF TEST SUBSTANCE
- Washing (if done): Distilled water was used to remove residual test item.
TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 2000 mg/kg bw - Duration of exposure:
- 1. not specified
2. 24 hours - Doses:
- 1. 3000 mg/kg
2. A single dose of 2000 mg of the test item per kilogram of body weight was administered to ten rats (five males and five females). - No. of animals per sex per dose:
- 1. not specified
2. 10 (5/sex). - Control animals:
- other: 1. not specified 2. yes
- Details on study design:
- 1. not specified
2. - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Twice daily
- Necropsy of survivors performed: Yes
- Other examinations performed: Clinical Observations and General Appearance:Animals were observed for clinical signs, mortality, until sacrifice.
Onset, duration and severity of any sign were recorded. The clinical signs and mortality observations were conducted at 10, 30, 60 minutes, 2, 4 and 6 hours on the day of dosing and once daily thereafter for 14 day. Daily observation was done as far as possible at the same time.
The observations were included general clinical signs, observations of eyes, mucous membranes, respiratory, circulatory system and behavior pattern.
Evaluation of Dermal Reaction: Dermal reaction was observed daily for study period of 14 days.
Body weights: Individual animal body weights were recorded pre-test (prior to administration of the test item), day 7 and at termination on day 14.
Gross Pathology: Necropsy was performed on animals surviving at the end of the study. Macroscopic examination of all the orifices, cavities and tissues were made and the findings were recorded. All animals surviving the study period were sacrificed by the carbon dioxide asphyxiation technique (day 15). - Statistics:
- 1. not specified
2. not specified - Preliminary study:
- 1. not specified
2. not specified - Sex:
- not specified
- Dose descriptor:
- LD50
- Effect level:
- > 3 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: No mortality was observed
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: No mortality was observed
- Mortality:
- 1. No mortality was observed at 3000 mg/kg bw.
2. Sex : Male Group I - Animal treated at the dose level of 2000 mg/kg: All animals survived through the study period of 14 days.
Sex : Female Group I – Animal treated at the dose level of 2000 mg/kg: All animals survived through the study period of 14 days. - Clinical signs:
- 1. not specified
2. Sex : Male Group I - Animal treated at the dose level of 2000 mg/kg body weight did not result in any signs of toxicity during the study period of 14 days.
Sex : Female Group I - Animal treated at the dose level of 2000 mg/kg body weight did not result in any signs of toxicity during the study period of 14 days. - Body weight:
- 1. not specified
2. Sex : Male Group I (2000 mg/kg) - Percent body weight gain after 7 days and 14 days was found to be 8.88% and 18.87% respectively.
Sex : Female Group I (2000 mg/kg) - Percent body weight gain after 7 days and 14 days was found to be 4.29% and 9.60% respectively. - Gross pathology:
- 1. not specified
2. Gross pathological examination did not reveal any abnormalities in animals from 2000 mg/kg dose group. - Other findings:
- 1. not specified
2. - Other observations: Evaluation of Dermal Reaction
Sex : Male Group I - Animal treated at the dose level of 2000 mg/kg body weight did not result in any skin reaction during the study period of 14 days.
Sex : Female Group I - Animal treated at the dose level of 2000 mg/kg body weight did not result in any skin reaction during the study period of 14 days. - Interpretation of results:
- other: Not classified
- Conclusions:
- According to CLP regulation the test chemical 1,3-Benzenediamine, coupled with diazotized m-phenylenediamine, acetates (CAS no.: 84281-74-3) cannot be classified for acute dermal toxicity, as the LD50 value is >2000 mg/kg bw
- Executive summary:
Data available for the structurally similar read across chemicals has been reviewed to determine the acute dermal toxicity of the test chemical 1,3-Benzenediamine, coupled with diazotized m-phenylenediamine, acetates (CAS no.: 84281-74-3). The studies are as mentioned below:
1. Acute Dermal toxicity study of test chemical was conducted in rats at the concentration of 3000 mg/kg bw. No mortality was observed in treated rats at 3000 mg/kg bw. Therefore, LD50 was considered to be >3000 mg/kg bw, when rats were treated with test chemical by dermal application to the skin.
2. The acute dermal toxicity study was designed and conducted for the test chemical in Sprague Dawley rats. The test item was applied to shorn skin of 5 male and 5 female animals at 2000 mg/kg body weight. Administration of the test item at 2000 mg/kg did not result in any skin reaction at the site of application during the study period of 14 days. Administration of the test item did not result in any signs of toxicity and mortality during the study period of 14 days. Animals exhibited normal body weight gain through the study period of 14 days. Gross pathological examination did not reveal any abnormalities attributable to the treatment. Hence, the LD50 value was considered to be >2000 mg/kg bw, when male and female Sprague Dawley rats were semiocclusively treated with test chemical by dermal application following 14 days of observation period according to OECD Guideline 402 (Acute Dermal Toxicity).
Thus, based on the above summarised studies, 1,3-Benzenediamine, coupled with diazotized m-phenylenediamine, acetates (CAS no.: 84281-74-3) and it’s structurally and functionally similar read across substances, it can be concluded that LD50 value is >2000 mg/kg bw. Thus, comparing this value with the criteria of CLP regulation, 1,3-Benzenediamine, coupled with diazotized m-phenylenediamine, acetates (CAS no.: 84281-74-3) cannot be classified for acute dermal toxicity.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 3 000 mg/kg bw
- Quality of whole database:
- Data is Klimisch 2 and from secondary source.
Additional information
Acute oral Toxicity:
Data available for the structurally and functionally similar read across chemicals has been reviewed to determine the acute oral toxicity of the test chemical 1,3-Benzenediamine, coupled with diazotized m-phenylenediamine, acetates (CAS no.: 84281-74-3). The studies are as mentioned below:
1. Acute oral toxicity test was conducted using test chemical in 20 Tif. RAI rats (10 males/10 females), bred under SPF conditions at the dose concentration of 6000 and 10000 mg/kg bw. The test substance was weighed into an Erlenmeyer flask on a Mettler balance. It was suspended at 50 and 60 % with carboxymethylcellulose 2 % and administered by oral intubation. Before treatment the suspension was homogeneously dispersed with an Ultra-Turrax and during treatment it was kept stable with a magnetic stirrer. Mortality and general symptoms was observed at 1 h, 24 h, 48 h, and 7 days. Animals were observed for clinical signs. No mortality was observed at any of the dose in treated rats. Within 2 hours after treatment the rats of both dosage groups showed dyspnoea, exophthalmus, curved position and ruffled fur. The animals had recovered within 4 to 6 days. They were killed and autopsied after an observation period of 7 days. No substance related gross organ changes were seen. Hence, LD50 was considered to be >10000 mg/kg bw, when Tif. RAI rats were treated with test chemical via oral gavage route.
2. Acute oral toxicity study of test chemical was conducted in rats at the concentration of 5000 mg/kg bw. No mortality was observed in treated rats at 5000 mg/kg bw. Therefore, LD50 was considered to be >5000 mg/kg bw, when rats were treated with test chemical via oral route.
Thus, based on the above summarised studies, 1,3-Benzenediamine, coupled with diazotized m-phenylenediamine, acetates (CAS no.: 84281-74-3) and it’s structurally and functionally similar read across substance, it can be concluded that LD50 value is >2000 mg/kg bw. Thus, comparing this value with the criteria of CLP regulation, 1,3-Benzenediamine, coupled with diazotized m-phenylenediamine, acetates cannot be classified for acute oral toxicity.
Acute Inhalation Toxicity:
The acute inhalation toxicity study need not be conducted because exposure of humans via inhalation route is not likely taking into account due to the low vapour pressure of the substance 1,3-Benzenediamine, coupled with diazotized m-phenylenediamine, acetates (CAS no.: 84281-74-3), which is reported to be 1.29E-32 mmHg. Thus, exposure to inhalable dust, mist and vapour of the chemical 1,3-Benzenediamine, coupled with diazotized m-phenylenediamine, acetates is highly unlikely. Therefore this study is considered for waiver.
Acute dermal Toxicity:
Data available for the structurally similar read across chemicals has been reviewed to determine the acute dermal toxicity of the test chemical 1,3-Benzenediamine, coupled with diazotized m-phenylenediamine, acetates (CAS no.: 84281-74-3). The studies are as mentioned below:
1. Acute Dermal toxicity study of test chemical was conducted in rats at the concentration of 3000 mg/kg bw. No mortality was observed in treated rats at 3000 mg/kg bw. Therefore, LD50 was considered to be >3000 mg/kg bw, when rats were treated with test chemical by dermal application to the skin.
2. The acute dermal toxicity study was designed and conducted for the test chemical in Sprague Dawley rats. The test item was applied to shorn skin of 5 male and 5 female animals at 2000 mg/kg body weight. Administration of the test item at 2000 mg/kg did not result in any skin reaction at the site of application during the study period of 14 days. Administration of the test item did not result in any signs of toxicity and mortality during the study period of 14 days. Animals exhibited normal body weight gain through the study period of 14 days. Gross pathological examination did not reveal any abnormalities attributable to the treatment. Hence, the LD50 value was considered to be >2000 mg/kg bw, when male and female Sprague Dawley rats were semiocclusively treated with test chemical by dermal application following 14 days of observation period according to OECD Guideline 402 (Acute Dermal Toxicity).
Thus, based on the above summarised studies, 1,3-Benzenediamine, coupled with diazotized m-phenylenediamine, acetates (CAS no.: 84281-74-3) and it’s structurally and functionally similar read across substances, it can be concluded that LD50 value is >2000 mg/kg bw. Thus, comparing this value with the criteria of CLP regulation, 1,3-Benzenediamine, coupled with diazotized m-phenylenediamine, acetates (CAS no.: 84281-74-3) cannot be classified for acute dermal toxicity.
Justification for classification or non-classification
Based on the above studies, 1,3-Benzenediamine, coupled with diazotized m-phenylenediamine, acetates (CAS no.: 84281-74-3) and it’s structurally and functionally similar read across substances, it can be concluded that LD50 value is >2000 mg/kg bw for acute oral and dermal toxicity. Thus, comparing these values with the criteria of CLP regulation, 1,3-Benzenediamine, coupled with diazotized m-phenylenediamine, acetates cannot be classified for acute dermal toxicity. For acute inhalation toxicity wavier was added so, not possible to classify.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.